IonQ is trading at $32.89, down 5.29%, with weakness tied primarily to investor concerns about dilution from its proposed all-stock acquisition of Elisity.

  • The proposed acquisition is valued at up to $1.3 billion and was announced October 12.
  • October 14 coverage continued to cite dilution concerns.
  • Futures were modestly lower, but the supplied context does not establish broad-market weakness as the main driver; no separate October 14 company announcement was identified.